Press release
Liquid Biopsy Market worth $6.25 billion by 2030, growing at a CAGR of 20.37% - Exclusive Report by 360iResearch
Liquid Biopsy Market | 360iResearch
Request Sample Copy of this Report @ https://www.360iresearch.com/library/intelligence/liquid-biopsy?utm_source=openpr&utm_medium=referral&utm_campaign=sample
Market Segmentation & Coverage:
This research report categorizes the Liquid Biopsy Market in order to forecast the revenues and analyze trends in each of following sub-markets:
Based on Biomarkers, market is studied across Cell-free DNA, Circulating Tumor Cells, Circulating Tumor DNA, Exosome, and Extracellular Vesicles. The Cell-free DNA commanded largest market share of 18.34% in 2022, followed by Circulating Tumor DNA.
Based on Sample, market is studied across Blood Based and Urine Based. The Blood Based commanded largest market share of 52.12% in 2022, followed by Urine Based.
Based on Type, market is studied across Assay Kits, Instruments, and Services. The Assay Kits commanded largest market share of 44.23% in 2022, followed by Instruments.
Based on Technology, market is studied across Multi-gene Parallel Analysis using NGS and Single-gene Analysis using PCR Microarrays. The Single-gene Analysis using PCR Microarrays commanded largest market share of 62.12% in 2022, followed by Multi-gene Parallel Analysis using NGS.
Based on Indication, market is studied across Cancer Indication and Non-Cancer Indication. The Cancer Indication is further studied across Breast Cancer, Colorectal Cancer, Lung Cancer, Melanoma, and Prostate Cancer. The Non-Cancer Indication commanded largest market share of 61.23% in 2022, followed by Cancer Indication.
Based on End-User, market is studied across Academic & Research Centers, Clinical Diagnostic Laboratories, Hospitals, and Physician's Office Laboratories. The Clinical Diagnostic Laboratories commanded largest market share of 44.23% in 2022, followed by Hospitals.
Based on Application, market is studied across Early Cancer Screening, Recurrence Monitoring, Therapy Selection, and Treatment Monitoring. The Treatment Monitoring commanded largest market share of 32.12% in 2022, followed by Early Cancer Screening.
Based on Region, market is studied across Americas, Asia-Pacific, and Europe, Middle East & Africa. The Americas is further studied across Argentina, Brazil, Canada, Mexico, and United States. The United States is further studied across California, Florida, Illinois, New York, Ohio, Pennsylvania, and Texas. The Asia-Pacific is further studied across Australia, China, India, Indonesia, Japan, Malaysia, Philippines, Singapore, South Korea, Taiwan, Thailand, and Vietnam. The Europe, Middle East & Africa is further studied across Denmark, Egypt, Finland, France, Germany, Israel, Italy, Netherlands, Nigeria, Norway, Poland, Qatar, Russia, Saudi Arabia, South Africa, Spain, Sweden, Switzerland, Turkey, United Arab Emirates, and United Kingdom. The Americas commanded largest market share of 42.54% in 2022, followed by Europe, Middle East & Africa.
FPNV Positioning Matrix:
The FPNV Positioning Matrix is essential for assessing the Liquid Biopsy Market. It provides a comprehensive evaluation of vendors by examining key metrics within Business Strategy and Product Satisfaction, allowing users to make informed decisions based on their specific needs. This advanced analysis then organizes these vendors into four distinct quadrants, which represent varying levels of success: Forefront (F), Pathfinder (P), Niche (N), or Vital(V).
Market Share Analysis:
The Market Share Analysis offers an insightful look at the current state of vendors in the Liquid Biopsy Market. By comparing vendor contributions to overall revenue, customer base, and other key metrics, we can give companies a greater understanding of their performance and what they are up against when competing for market share. The analysis also sheds light on just how competitive any given sector is about accumulation, fragmentation dominance, and amalgamation traits over the base year period studied.
Key Company Profiles:
The report delves into recent significant developments in the Liquid Biopsy Market, highlighting leading vendors and their innovative profiles. These include Angle PLC, Bio-Rad Laboratories, Inc., Bio-Techne Corporation, Biocartis NV, Biocept, Inc., CellMax, Inc., Circulogene, Diacarta, Dxcover Limited, Epic Sciences, Exact Sciences Corporation, Foundation Medicine, Inc., Freenome Holdings, Inc., Guardant Health, Inc., Illumina Inc., Inivata Limited by NeoGenomics, Inc., Laboratory Corporation of America Holdings, Lucence Health Inc., LungLife AI, Inc., MDxHealth SA, Menarini Silicon Biosystems Inc., Myriad Genetics, Inc., Natera, Inc., Neogenomics, Inc., OncoDNA, PerkinElmer, Inc., Personalis, Inc., SAGA Diagnostics AB, Strand Life Sciences Pvt. Ltd., Sysmex Corporation, and Tempus.
Key Topics Covered:
1. Preface
2. Research Methodology
3. Executive Summary
4. Market Overview
5. Market Insights
6. Liquid Biopsy Market, by Biomarkers
7. Liquid Biopsy Market, by Sample
8. Liquid Biopsy Market, by Type
9. Liquid Biopsy Market, by Technology
10. Liquid Biopsy Market, by Indication
11. Liquid Biopsy Market, by End-User
12. Liquid Biopsy Market, by Application
13. Americas Liquid Biopsy Market
14. Asia-Pacific Liquid Biopsy Market
15. Europe, Middle East & Africa Liquid Biopsy Market
16. Competitive Landscape
17. Competitive Portfolio
18. Appendix
The report provides insights on the following pointers:
1. Market Penetration: Provides comprehensive information on the market offered by the key players
2. Market Development: Provides in-depth information about lucrative emerging markets and analyzes penetration across mature segments of the markets
3. Market Diversification: Provides detailed information about new product launches, untapped geographies, recent developments, and investments
4. Competitive Assessment & Intelligence: Provides an exhaustive assessment of market shares, strategies, products, certification, regulatory approvals, patent landscape, and manufacturing capabilities of the leading players
5. Product Development & Innovation: Provides intelligent insights on future technologies, R&D activities, and breakthrough product developments
The report answers questions such as:
1. What is the market size and forecast of the Liquid Biopsy Market?
2. Which are the products/segments/applications/areas to invest in over the forecast period in the Liquid Biopsy Market?
3. What is the competitive strategic window for opportunities in the Liquid Biopsy Market?
4. What are the technology trends and regulatory frameworks in the Liquid Biopsy Market?
5. What is the market share of the leading vendors in the Liquid Biopsy Market?
6. What modes and strategic moves are considered suitable for entering the Liquid Biopsy Market?
Read More @ https://www.360iresearch.com/library/intelligence/liquid-biopsy?utm_source=openpr&utm_medium=referral&utm_campaign=analyst
Contact 360iResearch
Mr. Ketan Rohom
Sales & Marketing,
Office No. 519, Nyati Empress,
Opposite Phoenix Market City,
Vimannagar, Pune, Maharashtra,
India - 411014.
sales@360iresearch.com
+1-530-264-8485
+91-922-607-7550
About 360iResearch
360iResearch is a market research and business consulting company headquartered in India, with clients and focus markets spanning the globe.
We are a dynamic, nimble company that believes in carving ambitious, purposeful goals and achieving them with the backing of our greatest asset - our people.
Quick on our feet, we have our ear to the ground when it comes to market intelligence and volatility. Our market intelligence is diligent, real-time and tailored to your needs, and arms you with all the insight that empowers strategic decision-making.
Our clientele encompasses about 80% of the Fortune Global 500, and leading consulting and research companies and academic institutions that rely on our expertise in compiling data in niche markets. Our meta-insights are intelligent, impactful and infinite, and translate into actionable data that support your quest for enhanced profitability, tapping into niche markets, and exploring new revenue opportunities.
This release was published on openPR.
Permanent link to this press release:
Copy
Please set a link in the press area of your homepage to this press release on openPR. openPR disclaims liability for any content contained in this release.
You can edit or delete your press release Liquid Biopsy Market worth $6.25 billion by 2030, growing at a CAGR of 20.37% - Exclusive Report by 360iResearch here
News-ID: 3239455 • Views: …
More Releases from 360iResearch
Rising Incidence of Human Metapneumovirus in Vulnerable Populations Boosts Globa …
In recent years, the silent ascent of human metapneumovirus (HMPV) infections has begun to capture significant attention within the realm of infectious diseases. As we advance in medical science, unraveling complexities of age-old pathogens like common influenza or emerging illnesses like COVID-19, a critical discourse has been emerging around HMPV. Particularly, there seems to be a burgeoning acknowledgment of its growing impact on vulnerable global populations, propelling an increased demand…
The Meat Alternatives Market size was estimated at USD 9.39 billion in 2023 and …
From Appetite to Advocacy: The Rising Demand for Meat Alternatives
In recent years, the global food industry has been undergoing a remarkable transformation, driven primarily by an increasing consumer demand for healthier, sustainable, and ethically sourced food products. This seismic shift has brought traditional meat alternatives and high-protein plant-based foods into the spotlight. As the world becomes more conscious of the implications of meat consumption on health and the environment, the…
The Mobility-as-a-Service Market size was estimated at USD 264.80 billion in 202 …
Unpacking the Surge in Investments and Collaborations to Bolster Mobility-as-a-Service
In recent years, as urban landscapes continually evolve, a transformative shift known as Mobility-as-a-Service (MaaS) has reshaped the way we perceive transportation. Marked by the integration of various forms of transport services into a single accessible on-demand mobility solution, MaaS is rapidly gaining traction across global cities. As an emerging paradigm, it's not just shaping the future of travel but also…
The Data Center Services Market size was estimated at USD 56.65 billion in 2023 …
Smart City Revolutions: Why Data Center Colocation is the Future Backbone
In the era of digital transformation, urban landscapes across the globe are undergoing a seismic shift toward becoming "smart cities." The concept of a smart city revolves around using digital technology, IoT (Internet of Things), AI, and data analytics at an unprecedented scale to improve urban infrastructure, manage resources efficiently, and enhance the quality of life for citizens. A vital…
More Releases for Liquid
Vitamins: The Liquid Goldmine in the Booming Liquid Dietary Supplements Market
The liquid dietary supplements market is experiencing a surge in popularity, driven by consumers seeking convenient and effective ways to boost their health and wellness. Among the diverse offerings, the vitamins segment stands out as a high-opportunity area, catering to a wide range of health needs and preferences.
Market Dynamics and Growth Drivers
Liquid vitamins offer a compelling alternative to traditional pills and capsules, providing faster absorption, easier consumption, and customizable dosages.…
Thermoelectric Assemblies Market, By Type (Air to Air, Direct to Air, Liquid to …
The thermoelectric assemblies market is expected to witness market growth at a rate of 8.25% in the forecast period of 2021 to 2028. Data Bridge Market Research report on thermoelectric assemblies market provides analysis and insights regarding the various factors expected to be prevalent throughout the forecast period while providing their impacts on the market's growth. The rise in the application of thermoelectric assemblies in the food and beverage industry…
Southeast Asia Liquid Gases Market : Growing with a CAGR of 7.1%, By Type (Liqui …
Southeast Asia liquid gases market is expected to grow significantly in the forecast period of 2023 to 2030. Data Bridge Market Research analyses that the market is growing with a CAGR of 7.1% in the forecast period of 2023 to 2030 and is expected to reach USD 5,042,237.33 thousand by 2030. The major factor driving the growth of the liquid gases market is the rising demand of fresh packaged products…
Southeast Asia Liquid Gases Market growing with a CAGR of 7.1%, By Type (Liquid …
Southeast Asia liquid gases market is expected to grow significantly in the forecast period of 2023 to 2030. Data Bridge Market Research analyses that the market is growing with a CAGR of 7.1% in the forecast period of 2023 to 2030 and is expected to reach USD 5,042,237.33 thousand by 2030. The major factor driving the growth of the liquid gases market is the rising demand of fresh packaged products…
Southeast Asia liquid gases market growing with a CAGR of 7.1%, Size, Share, Tre …
Southeast Asia liquid gases market is expected to grow significantly in the forecast period of 2023 to 2030. Data Bridge Market Research analyses that the market is growing with a CAGR of 7.1% in the forecast period of 2023 to 2030 and is expected to reach USD 5,042,237.33 thousand by 2030. The major factor driving the growth of the liquid gases market is the rising demand of fresh packaged products…
Dual Chamber Prefilled Syringes Market 2021 by Product (Liquid/Powder, Liquid/Li …
The Dual Chamber Prefilled Syringes Market report examines the market size by vital countries/regions, product type, application, historical data, and estimate to forecast. It helps to understand the structure of the Dual Chamber Prefilled Syringes Market by recognizing its different sub-segments. Furthermore, the report focuses on key market players to determine, describe and analyze the value, market share, market competition landscape, SWOT analysis, and development plans in the next few…
